Stock Chart
NAMS
Type: SELL wallstreet
Strike: $45
Premium: $4.44
Expiry: Jan 15, 2027
Target: $48
Score: -27
LEAPs are long-term options (1+ year) with less time decay.
Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech
Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity
Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Technical Chart
About NAMS - NewAmsterdam Pharma Company N.V. Ordinary Shares
NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.
Key Statistics
More NAMS Analysis
This NAMS stock chart provides comprehensive technical analysis including candlestick patterns, volume profile analysis, and options open interest data. Track NAMS's price movements with trendlines, gamma walls, and key support/resistance levels.